Received Sep 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
no adverse event; Pharmacist stated 2 doses of MMR-II was administered in a 5 years old patient; This spontaneous report was received from a Pharmacist and refers to a 5-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 13-Sep-2025, the patient started therapy with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), (dose, anatomical location, route of administration, lot # and expiration date were not reported) reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) lot # and expiration date were not reported). On 16-Sep-2025, the patient received second dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), (lot # and expiration date were not reported) reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT)(inappropriate schedule od product administration) at another facility. No adverse event was reported.
sterile diluent